MTOR and colorectal carcinoma: Since Dialister has been associated with higher cytotoxicity in irinotecan-treated CRC patients [39], our data suggest that the use of this strain, as faecal biomarker, may potentially predict the toxicity of chemotherapy in CRCs with impaired mTOR signalling pathway.